26/05/2015 02:29:52 Cookie Policy Free Membership Login

Glaxosmithkline Share Chat - GSK

Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change Price Change % Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +14.00 +0.97% 1,464.50 1,467.50 1,468.00 1,473.50 1,447.00 1,452.00 7,360,792 16:35:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 23,006.0 2,968.0 57.3 25.6 71,233.37

Glaxosmithkline Bulletin Board

DateSubjectDiscuss
25/5/2015
18:33
filtering works. z
by zeppo on Glaxosmithkline - The recovery
25/5/2015
15:59
Spread Betting and CFDs May Magazine edition now online at http://bit.ly/1aCCT0d This month's premium features includes General Election 2015: Whoever Wins, Britain Loses - Interview with David Buik, Zak Mir interviews a City Legend - The Mind of the Master Investor - Small Cap Corner, Tomorrow's Jam Today - FTSE 100, where Next?
by lak342 on Glaxosmithkline - The recovery
25/5/2015
12:15
Mentioned previously that the CEO has about 12 months to restore GSK to growth, article in the FT today along similar lines.
by essentialinvestor on Glaxosmithkline - The recovery
23/5/2015
21:27
montyhedge 15 May'15 - 15:34 - 10749 of 10773 1050p target. Dividend in my view will be cut, p.e 24 so 700p target possible. I'm being generous. KEEP POSTING DOBBY! LOL WHERE IS IT NOW £14.64.50p and it's heading back to £15
by christh on Glaxosmithkline - The recovery
23/5/2015
19:36
Depends which authorities.
by alphorn on Glaxosmithkline - The recovery
23/5/2015
14:23
What happens to the dynamics of a Pfizer move for GSK with a subsequent move of domicile to UK/London as has been suggested? Would the latter event negate possible hostility by authorities?
by cyberian on Glaxosmithkline - The recovery
23/5/2015
11:02
very good piece on why a gsk/pfizer tie-up will most likely never occur hTTp://tinyurl.com/nvf2qgt
by unastubbs on Glaxosmithkline - The recovery
21/5/2015
10:51
Well I don't think its much more than some idle analyst pulling a story out of the air. FWIW I would vote no - US companies are run with too much short termism for my liking.
by dr biotech on Glaxosmithkline - The recovery
21/5/2015
10:38
Speculation. Speculation. Why not let GSK takeover AZN, then let Pfizer take over the combined company?
by jadeticl3 on Glaxosmithkline - The recovery
21/5/2015
08:44
...... a smoke screen that is pushing up the SP - nice one ! NR
by nik rosa on Glaxosmithkline - The recovery
21/5/2015
07:41
imo, its a smoke screen, they are coming back for Astra Z !! They were waiting for goverment situation..........city strong rumour.
by topcar on Glaxosmithkline - The recovery
20/5/2015
20:15
Guardian: Elsewhere analysts at Deutsche Bank looked at the prospects for GlaxoSmithKline, up 5p at 1447.5p being a takeover target for US rival Pfizer hTTp://tinyurl.com/nverzhc hTTp://tinyurl.com/nbebfco
by unastubbs on Glaxosmithkline - The recovery
19/5/2015
16:13
It is a bit odd though - are we just going to get the 80p special over a few years now rather than one (ie would they have cut the dividend). I didn't want the special dividend. I am quite happy to have one from a company that has excess capital, but I feel that it should be put to better use paying off debt or into R&D or acquisition. GSK is at a cross roads - selling bulk vaccines as a commodity will make it a very different beast than it was before. As someone said it may be more like a utility. Thats not a bad thing if they have steady repeatable profits without having to be concerned about patents. But that is assuming they can sell enough to replace the falling sales of their other products.
by dr biotech on Glaxosmithkline - The recovery
19/5/2015
15:45
There were many on this thread that did not support the 83p handout and I guess that many influential shareholders had a say in the change of stance. If the company story is correct the problem of paying the divi is real but short term. If not then nothing they say is worth discussing. I am accepting their word for now, so the move to a 20p special in addition to the 80p normal will please me and support divi over 2015 and 2016. By then we should know if the new products are making up the loss from Advair.
by jadeticl3 on Glaxosmithkline - The recovery
19/5/2015
11:30
... well I agree with Monty on this one .... bought in before the divi ... sometimes a mistake if it continues to drop as GSK did .. but bailed this morning for pennies .... Looks to me as though the special dividend has been cut to support the 5% share promise which doesn't look too smart .... .... happy to be wrong and on the sidelines without a loss.
by keith95 on Glaxosmithkline - The recovery
18/5/2015
08:30
Anyone who reads the IC and takes it seriously needs help
by toffeeman on Glaxosmithkline - The recovery
17/5/2015
19:19
They love him on the BT thread - Not!
by ianood on Glaxosmithkline - The recovery
17/5/2015
09:35
Filtering works! z
by zeppo on Glaxosmithkline - The recovery
16/5/2015
18:18
Well they obviously can Read the bible.
by racg on Glaxosmithkline - The recovery
16/5/2015
18:01
Read the Investors Chronicle. Not very flattering. The only thing holding this shareprice up is the dividend yield. They can't keep paying that rate coming years.
by montyhedge on Glaxosmithkline - The recovery
432  431  430  429  428  427  426  425  424  423  422  421  >>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 150526 02:29